Logo image of ARIS.CA

ARIS MINING CORP (ARIS.CA) Stock Fundamental Analysis

TSX:ARIS - Toronto Stock Exchange - CA04040Y1097 - Common Stock - Currency: CAD

10.97  -0.01 (-0.09%)

Fundamental Rating

5

Taking everything into account, ARIS scores 5 out of 10 in our fundamental rating. ARIS was compared to 797 industry peers in the Metals & Mining industry. ARIS scores excellent on profitability, but there are concerns on its financial health. ARIS is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year ARIS was profitable.
ARIS had a positive operating cash flow in the past year.
Of the past 5 years ARIS 4 years were profitable.
ARIS had a positive operating cash flow in each of the past 5 years.
ARIS.CA Yearly Net Income VS EBIT VS OCF VS FCFARIS.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M

1.2 Ratios

ARIS's Return On Assets of 1.33% is amongst the best of the industry. ARIS outperforms 86.45% of its industry peers.
With an excellent Return On Equity value of 3.29%, ARIS belongs to the best of the industry, outperforming 87.95% of the companies in the same industry.
ARIS has a Return On Invested Capital of 5.77%. This is amongst the best in the industry. ARIS outperforms 91.84% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ARIS is below the industry average of 11.45%.
Industry RankSector Rank
ROA 1.33%
ROE 3.29%
ROIC 5.77%
ROA(3y)0.71%
ROA(5y)4.01%
ROE(3y)1.68%
ROE(5y)8.18%
ROIC(3y)6.8%
ROIC(5y)10.94%
ARIS.CA Yearly ROA, ROE, ROICARIS.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100

1.3 Margins

The Profit Margin of ARIS (4.94%) is better than 90.72% of its industry peers.
In the last couple of years the Profit Margin of ARIS has declined.
With an excellent Operating Margin value of 27.27%, ARIS belongs to the best of the industry, outperforming 93.73% of the companies in the same industry.
In the last couple of years the Operating Margin of ARIS has declined.
ARIS has a better Gross Margin (35.19%) than 92.60% of its industry peers.
In the last couple of years the Gross Margin of ARIS has declined.
Industry RankSector Rank
OM 27.27%
PM (TTM) 4.94%
GM 35.19%
OM growth 3Y-13.31%
OM growth 5Y-7.27%
PM growth 3Y-53.75%
PM growth 5YN/A
GM growth 3Y-11.09%
GM growth 5Y-5.36%
ARIS.CA Yearly Profit, Operating, Gross MarginsARIS.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ARIS is destroying value.
The number of shares outstanding for ARIS has been increased compared to 1 year ago.
ARIS has more shares outstanding than it did 5 years ago.
ARIS has a better debt/assets ratio than last year.
ARIS.CA Yearly Shares OutstandingARIS.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
ARIS.CA Yearly Total Debt VS Total AssetsARIS.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

ARIS has an Altman-Z score of 1.16. This is a bad value and indicates that ARIS is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.16, ARIS is in line with its industry, outperforming 49.31% of the companies in the same industry.
A Debt/Equity ratio of 0.59 indicates that ARIS is somewhat dependend on debt financing.
ARIS has a Debt to Equity ratio of 0.59. This is in the lower half of the industry: ARIS underperforms 73.78% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF N/A
Altman-Z 1.16
ROIC/WACC0.65
WACC8.9%
ARIS.CA Yearly LT Debt VS Equity VS FCFARIS.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

ARIS has a Current Ratio of 2.10. This indicates that ARIS is financially healthy and has no problem in meeting its short term obligations.
ARIS has a Current ratio of 2.10. This is comparable to the rest of the industry: ARIS outperforms 56.09% of its industry peers.
ARIS has a Quick Ratio of 1.81. This is a normal value and indicates that ARIS is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.81, ARIS perfoms like the industry average, outperforming 55.58% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.1
Quick Ratio 1.81
ARIS.CA Yearly Current Assets VS Current LiabilitesARIS.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

6

3. Growth

3.1 Past

ARIS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 103.13%, which is quite impressive.
ARIS shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 19.72%.
ARIS shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 23.71% yearly.
EPS 1Y (TTM)103.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%237.5%
Revenue 1Y (TTM)19.72%
Revenue growth 3Y21.98%
Revenue growth 5Y23.71%
Sales Q2Q%73.62%

3.2 Future

ARIS is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -5.73% yearly.
ARIS is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.50% yearly.
EPS Next Y22.82%
EPS Next 2Y-27.78%
EPS Next 3Y-27.1%
EPS Next 5Y-5.73%
Revenue Next Year-3.43%
Revenue Next 2Y0.95%
Revenue Next 3Y4.05%
Revenue Next 5Y13.5%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
ARIS.CA Yearly Revenue VS EstimatesARIS.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 500M 1B
ARIS.CA Yearly EPS VS EstimatesARIS.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 2 -2 -4

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 12.33 indicates a correct valuation of ARIS.
ARIS's Price/Earnings ratio is rather cheap when compared to the industry. ARIS is cheaper than 94.23% of the companies in the same industry.
ARIS's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.54.
The Price/Forward Earnings ratio is 14.18, which indicates a correct valuation of ARIS.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ARIS indicates a rather cheap valuation: ARIS is cheaper than 89.96% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 35.28. ARIS is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 12.33
Fwd PE 14.18
ARIS.CA Price Earnings VS Forward Price EarningsARIS.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

ARIS's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. ARIS is cheaper than 93.22% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.71
ARIS.CA Per share dataARIS.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ARIS has a very decent profitability rating, which may justify a higher PE ratio.
ARIS's earnings are expected to decrease with -27.10% in the coming years. This may justify a cheaper valuation.
PEG (NY)0.54
PEG (5Y)N/A
EPS Next 2Y-27.78%
EPS Next 3Y-27.1%

0

5. Dividend

5.1 Amount

No dividends for ARIS!.
Industry RankSector Rank
Dividend Yield N/A

ARIS MINING CORP

TSX:ARIS (8/7/2025, 7:00:00 PM)

10.97

-0.01 (-0.09%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)08-07 2025-08-07/amc
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.87B
Analysts81.82
Price Target14.15 (28.99%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-15.47%
Min EPS beat(2)-24.59%
Max EPS beat(2)-6.35%
EPS beat(4)0
Avg EPS beat(4)-30.87%
Min EPS beat(4)-47.01%
Max EPS beat(4)-6.35%
EPS beat(8)0
Avg EPS beat(8)-37.5%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-4.65%
Min Revenue beat(2)-5.38%
Max Revenue beat(2)-3.93%
Revenue beat(4)0
Avg Revenue beat(4)-4.95%
Min Revenue beat(4)-5.9%
Max Revenue beat(4)-3.93%
Revenue beat(8)0
Avg Revenue beat(8)-6.13%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)6.05%
PT rev (3m)14.04%
EPS NQ rev (1m)36.17%
EPS NQ rev (3m)120.69%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 12.33
Fwd PE 14.18
P/S 2.43
P/FCF N/A
P/OCF 7.23
P/B 1.62
P/tB 1.62
EV/EBITDA 8.71
EPS(TTM)0.89
EY8.11%
EPS(NY)0.77
Fwd EY7.05%
FCF(TTM)-0.11
FCFYN/A
OCF(TTM)1.52
OCFY13.84%
SpS4.51
BVpS6.76
TBVpS6.76
PEG (NY)0.54
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.33%
ROE 3.29%
ROCE 8.01%
ROIC 5.77%
ROICexc 6.59%
ROICexgc 6.59%
OM 27.27%
PM (TTM) 4.94%
GM 35.19%
FCFM N/A
ROA(3y)0.71%
ROA(5y)4.01%
ROE(3y)1.68%
ROE(5y)8.18%
ROIC(3y)6.8%
ROIC(5y)10.94%
ROICexc(3y)8.58%
ROICexc(5y)14.82%
ROICexgc(3y)8.58%
ROICexgc(5y)14.82%
ROCE(3y)9.44%
ROCE(5y)15.19%
ROICexcg growth 3Y-31.05%
ROICexcg growth 5Y-33.95%
ROICexc growth 3Y-31.05%
ROICexc growth 5Y-33.95%
OM growth 3Y-13.31%
OM growth 5Y-7.27%
PM growth 3Y-53.75%
PM growth 5YN/A
GM growth 3Y-11.09%
GM growth 5Y-5.36%
F-Score7
Asset Turnover0.27
Health
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF N/A
Debt/EBITDA 2.61
Cap/Depr 548.86%
Cap/Sales 36.08%
Interest Coverage 4.75
Cash Conversion 99.53%
Profit Quality N/A
Current Ratio 2.1
Quick Ratio 1.81
Altman-Z 1.16
F-Score7
WACC8.9%
ROIC/WACC0.65
Cap/Depr(3y)395.74%
Cap/Depr(5y)328%
Cap/Sales(3y)29.9%
Cap/Sales(5y)24.47%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)103.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%237.5%
EPS Next Y22.82%
EPS Next 2Y-27.78%
EPS Next 3Y-27.1%
EPS Next 5Y-5.73%
Revenue 1Y (TTM)19.72%
Revenue growth 3Y21.98%
Revenue growth 5Y23.71%
Sales Q2Q%73.62%
Revenue Next Year-3.43%
Revenue Next 2Y0.95%
Revenue Next 3Y4.05%
Revenue Next 5Y13.5%
EBIT growth 1Y0.83%
EBIT growth 3Y-4.56%
EBIT growth 5Y1.41%
EBIT Next Year52.77%
EBIT Next 3Y31.28%
EBIT Next 5Y18.43%
FCF growth 1Y67.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y160.03%
OCF growth 3Y20.56%
OCF growth 5Y6.46%